Katia Messana
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Immune Cell Function and Interaction, T-cell and B-cell Immunology, MicroRNA in disease regulation
Most-Cited Works
- → PDGFR blockade is a rational and effective therapy for NPM-ALK–driven lymphomas(2012)125 cited
- → A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation(2014)47 cited
- → Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)(2018)35 cited
- → High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors(2021)26 cited
- → Abstract 5531: OTX015, a novel BET inhibitor, is a promising anticancer agent for multiple myeloma(2014)5 cited
- → Abstract 3853: Humanized NOD/Scid/IL2g-/- tumor grafts recapitulate primary anaplastic large cell lymphoma.(2013)4 cited
- → End9: an early-passage cell line defective in master HLA-I transcriptional coordinators(2022)
- → Identification of a New Subclass of ALK Negative Anaplastic Large Cell Lymphoma Expressing Aberrant Levels of ERBB4 Transcripts(2014)